|Articles|March 24, 2022
Structural elucidation for unknown compounds
Author(s)August Bioservices
Accurately identifying analytes that exceed the ICH identification thresholds is critical to a compound’s safety and stability profile in preparation for NDA filing.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
EMA Calls New EU Pharma Legislation Most Significant in Two Decades
2
European Parliament Revamps Pharmaceutical Policy Framework
3
Indivumed, URMC Launch Joint Venture for Patient-Centric Cancer R&D
4
Optimizing Pharmaceutical Manufacturing Efficiency
5
